InvestorsHub Logo
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

Re: Jobrano post# 28133

Thursday, 02/07/2013 9:16:43 PM

Thursday, February 07, 2013 9:16:43 PM

Post# of 158400
Jobrano:Roche and Regen met here>>>...in Nov 12-14,2012

Scroll Down...
http://www.ebdgroup.com/bioeurope/participants/index.php#R

I'm wondering if Adam and Johnny was there during the conference and heard something about the courtship of Roche and Regen...from Jason Coloma.

At Roche we are looking for first-in-class or best-in-class opportunities that address diseases of unmet medical need and have the potential to revolutionise the standard of care.. We focus on our main disease therapy areas – oncology and immunology, ophthalmology, virology, cardiometabolism and neuroscience–as well as looking at opportunities in promising technologies and early-stage collaborations. Beyond the asset, we always look for the right partnership and cultural fit.

Strategic Partnering
Within the organisation, the Strategic Partnering team will consider a range of deal types including mergers and acquisitions (M&A); alliances covering more than one therapeutic area; divestments; and in-licensing opportunities that do not fall within Roche’s key therapy areas of interest.

Bio-Matrix Scientific Group, Inc. ( PINKSHEETS : BMSN ) is a biotechnology company developing regenerative medicine therapies. The Company is focused on human therapies that address unmet medical needs.Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to cardiovascular, hematology, oncology and other indication

Miss Regen is a perfect match with Mr.Roche
They will meet and be together again this year...

Happy Reserving plenty of reservations under a pnny for the Grand-Wedding.

::)))

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.